Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Amateur Traders Corner -- Ignore unavailable to you. Want to Upgrade?

To: Paul A who wrote (17331)	12/14/2001 7:41:10 PM
From: Tom Hua	Read Replies (1) \| Respond to of 19633

Paul, incredible is an understatement, it's more like ADSPish. One heck of game and short squeeze. Next Friday I'll just roll all my Dec naked calls into Jan and just sit back and wait. Finally bought some Jan puts too. Script for the end result is well known, the timing is uncertain. Regards, Tom

To: Paul A who wrote (17331)	12/17/2001 12:36:35 PM
From: Tim Luke	Read Replies (1) \| Respond to of 19633

-------------------------------------------------------------------------------- Related Quote IMX 13.60 -0.40 delayed 20 mins - disclaimer Quote Data provided by Reuters Monday December 17, 12:30 pm Eastern Time Press Release SOURCE: Implant Sciences Corporation Implant Sciences Successfully Demonstrates Explosives Vapor Detection Device at Annual Meeting WAKEFIELD, Mass., Dec. 17 /PRNewswire/ -- Implant Sciences Corporation (Amex: IMX - news), which develops products for the radiation oncology, interventional cardiology, orthopedic, and explosives detection marketplaces, unveiled and demonstrated a prototype explosives and narcotics detection device at its Annual Meeting of Shareholders on December 14, 2001. The unique laser-based system can detect vapors from certain narcotics and at least five types of explosives at airborne concentrations measured in parts per trillion. In his comments to shareholders, Dr. Armini, President and Chief Executive Officer of Implant Sciences Corporation, stated, ``The worldwide explosives detection market, which management believes is expected to exceed $1 billion in size by the year 2003, is divided into two distinct segments -- Bulk Detection and Trace Detection. The U.S. Government has decreed that all passengers, baggage, and cargo carried on airlines must be screened thoroughly as soon as practical. Bulk Detection, which is primarily accomplished with x-ray techniques (either CAT scan or dual energy x-rays), involves very expensive systems that will likely be used to screen checked baggage at airports. Trace Detection relies upon an Ion Mobility Spectrometry (IMS) technique and is more cost-effective for screening passengers, carry-on luggage, and cargo for the presence of explosives or narcotics. Implant Sciences will pursue Trace Detection applications, and we believe our unique laser-based, battery powered portable, system will satisfy the requirements of this market. We also intend to pursue opportunities for explosives detection in postal systems and within the airline catering industry.'' Dr. Leonid Krasnobaev, who was primarily responsible for the development of the system, demonstrated its ability to collect and analyze vapors from miniscule samples of explosives and narcotics, without contacting the target materials. Within seconds, the device successfully detected, identified and quantified the presence of the explosives TNT and RDX (a primary component of C-4 plastic explosives), as well as THC, a chemical that is present in marijuana and heroin. The explosives detection device relies upon the Laser Resonant Enhanced Multi Photon Ionization (REMPI) phenomenon previously employed for isotope enrichment. The REMPI ion source is integrated with an Ion Mobility Spectrometer (IMS), an instrument that is currently used in explosives and narcotics detection. The combination of IMS with the REMPI ion source is unique to Implant Sciences' system and provides enhanced capability when compared with other IMS systems currently on the market. ``Our next step involves the submission of the explosives and narcotics detection system for approval by various governmental agencies, and we plan to proceed with such submissions on a timely basis,'' concluded Dr. Armini. Implant Sciences Corporation develops products for the medical device and explosives detection markets that primarily rely upon its proprietary ion implantation and thin film coatings technologies. The Company is headquartered in Wakefield, Massachusetts, and its common stock is listed on the American Stock Exchange under the ticker symbol ``IMX''. This press release includes statements that may constitute ``forward- looking'' statements, usually containing the words ``believe,'' ``estimate,'' ``project,'' ``expect'' or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products and services in the marketplace, the ability of the Company to develop effective new products and receive governmental approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. ,